-transparent.png){kind=logo}
Vesnarinone, a quinolinone derivative, induces apoptosis and differentiation in some tumor cell lines. We examined the antitumor effect of vesnarinone on three human hepatocellular carcinoma (HCC) cell lines. Vesnarinone suppressed the proliferation of all three HCC cell lines, but did not induce apoptosis and differentiation. Vesnarinone has also been reported to inhibit both nucleoside and nucleobase transport. Concomitant administration of vesnarinone and a de novo nucleotide synthesis inhibitor potentiated the growth-inhibitory effect of vesnarinone on HCC cells. Vesnarinone may be useful as a new biochemical modulator of anticancer agents.
Related Publications
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
January 2022,
International journal of molecular sciences,
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
January 2014,
TheScientificWorldJournal,
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
June 2012,
Molecular medicine reports,
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
September 2001,
Zhonghua zhong liu za zhi [Chinese journal of oncology],
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
February 2006,
Cytokine,
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
January 2022,
Journal of nutritional science and vitaminology,
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
April 1988,
Cancer letters,
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
November 2015,
International journal of oncology,
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
December 1983,
Gan to kagaku ryoho. Cancer & chemotherapy,
K Kubo, and
Y Matsuzaki, and
A Kato, and
S Terai, and
K Okita
January 2014,
World journal of gastroenterology,
